News

UBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN).
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. UBS has ...